Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Susceptibility of Human Cytomegalovirus (HCMV) Drug-resistant Viruses to a New Class of Acyclic Nucleoside Phosphonate Analogues (ANPs) — Graciela Andreï (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Susceptibility of Human Cytomegalovirus (HCMV) Drug-resistant Viruses to a New Class of Acyclic Nucleoside Phosphonate Analogues (ANPs)
Shared by
De Clercq Erik
KU Leuven
Susceptibility of Human Cytomegalovirus (HCMV) Drug-resistant Viruses to a New Class of Acyclic Nucleoside Phosphonate Analogues (ANPs)
Article
2008
en
Authors
+4 more
GA
Graciela Andreï
PF
Pierre Fiten
MK
Marcela Krečmerová
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
Isolation of vaccinia virus (VV) mutants resistant to different acyclic nucleoside phosphonate analogues (ANPs)
Graciela Andreï
,
A. HOLY
,
Pierre Fiten
,
Ghislain Opdenakker
,
De Clercq Erik
,
Robert Snoeck
Article
1991
Inhibition of cytomegalovirus replication by acyclic nucleoside phosphonate analogues: structure-activity relationship
Robert Snoeck
,
A. HOLY
,
Ivan Rosenberg
,
De Clercq Erik
Article
2003
New bicyclic nucleoside analogues (BCNAs) show selective and specific activity against human cytomegalovirus (HCMV)
Graciela Andreï
,
Jan Balzarini
,
De Clercq Erik
,
Ranjith Pathirana
,
Christopher McGuigan
,
Robert Snoeck
Article
1991
Chemotherapy of the acquired immune deficiency syndrome (AIDS): Acyclic nucleoside phosphonate analogues
De Clercq Erik
Article
1991
Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes
Jan Balzarini
,
Carlo Federico Perno
,
Dominique Schols
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.